Company Profile
Intuitive Stock Price, News & Analysis
- Ticker:
- ISRG
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Sunnyvale, California
Stock performance
373.71 USD (-0.40%)
Close
Last updated: August 6, 2026
142B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, ISRG closed down 0.40% at $373.71. No new same-company headline was identified in the current news window.
Company overview
Robotic-Assisted Surgery
Intuitive is a medical-technology company that pioneered robotic-assisted minimally invasive surgery. Its business combines capital systems, instruments, accessories, service and training across a large installed base.
Da Vinci Platform
The da Vinci surgical system enables surgeons to perform procedures through small incisions using articulated instruments and high-definition visualization. Da Vinci 5 is the newest generation and expands computing, sensing and ergonomic capabilities.
Ion Endoluminal System
Ion is a robotic platform for minimally invasive lung biopsy. Its flexible catheter and navigation technology allow clinicians to reach small peripheral pulmonary nodules for tissue acquisition.
Procedure-Driven Business Model
System placements expand Intuitive’s installed base, while each procedure generates recurring instrument and accessory demand. Service contracts, training and clinical support deepen hospital relationships and reinforce platform adoption.
Future catalysts
Intuitive Surgical is still a da Vinci story, with the market focused on procedure growth, da Vinci 5 rollout, and installed-base monetization. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
- 01
- 02
Intuitive Shares Vision for an AI-Enabled Future of Healthcare
Source: Intuitive
- 03
Intuitive Announces Second Quarter Earnings
Source: Intuitive
- 04
- 05
Intuitive Announces Innovations to Advance Quintuple Aim
Source: Intuitive
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Intuitive (ISRG)?
Intuitive (ISRG) most recently closed at 373.71 USD, a -0.40% move versus the previous session.
What is the market cap of Intuitive (ISRG)?
Intuitive currently has a market capitalization of 142B USD on BioPharmSignal.
What does Intuitive do?
Robotic-Assisted Surgery Intuitive is a medical-technology company that pioneered robotic-assisted minimally invasive surgery. Its business combines capital systems, instruments, accessories, service and training across a large installed base. Da Vinci Platform The da Vinci surgical system enables surgeons to perform procedures through small incisions using...
On which exchange is ISRG stock listed?
Intuitive (ISRG) is associated with NASDAQ, Sunnyvale, California, Biopharma.
What is Robotic-Assisted?
Robotic-Assisted Surgery Intuitive is a medical-technology company that pioneered robotic-assisted minimally invasive surgery.
Which conditions is Intuitive targeting with Robotic-Assisted?
Robotic-Assisted Surgery Intuitive is a medical-technology company that pioneered robotic-assisted minimally invasive surgery. Its business combines capital systems, instruments, accessories, service and training across a large installed base. Da Vinci Platform The da Vinci surgical system enables surgeons to perform procedures through small incisions using...
How does Intuitive describe recent progress with Robotic-Assisted?
Intuitive Surgical is still a da Vinci story, with the market focused on procedure growth, da Vinci 5 rollout, and installed-base monetization. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported...
What is Surgery?
Robotic-Assisted Surgery Intuitive is a medical-technology company that pioneered robotic-assisted minimally invasive surgery.